KRS Capital Management’s Procept Biorobotics PRCT Stock Holding History

KRS Capital Management’s Portfolio PRCT Stock Details PRCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.03M	Sell	45,610 -125	-0.3%	-$3.13K	0.48%	38
2026 Q1	$1.14M	Buy	45,735 +20	+0%	+$564	0.7%	31
2025 Q4	$1.44M	Sell	45,715 -295	-0.6%	-$9.78K	0.83%	23
2025 Q3	$1.64M	Buy	46,010 +20	+0%	+$913	0.99%	19
2025 Q2	$2.65M	Sell	45,990 -400	-0.9%	-$22.6K	1.77%	9
2025 Q1	$2.7M	Sell	46,390 -65	-0.1%	-$4.44K	2.15%	8
2024 Q4	$3.74M	Buy	46,455 +225	+0.5%	+$19.2K	2.64%	6
2024 Q3	$3.7M	Buy	46,230 +125	+0.3%	+$8.88K	2.7%	5
2024 Q2	$2.82M	Buy	+46,105	New	+$2.74M	2.11%	7

Other funds holding PRCT

Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

PCM

Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return

WRPWM

Werba Rubin Papier Wealth Management San Jose, California $824M AUM 24.76% 1-Year Est. Return

FRA

Frank Rimerman Advisors Palo Alto, California $1.77B AUM 41.18% 1-Year Est. Return

Banque Transatlantique Paris, France $4.66B AUM 33.26% 1-Year Est. Return

TFCM

Taylor Frigon Capital Management Scottsdale, Arizona $214M AUM 47.29% 1-Year Est. Return

RAM

Robocap Asset Management London, United Kingdom $124M AUM 95% 1-Year Est. Return

MIF

Mediolanum International Funds Dublin 1, Ireland $11.7B AUM 47.18% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

KRS Capital Management's PRCT Position: Q2 2026 in Review

KRS Capital Management reduced its Procept Biorobotics (PRCT) stake by 0.27% in Q2 2026, selling an estimated $3.13K and leaving 45,610 shares worth $1.03M. The position accounts for 0.48% of the portfolio, ranked #38.

KRS Capital Management first reported a position in PRCT in Q2 2024 and has held it in 9 quarters since. The position peaked at $3.74M in Q4 2024. 55 funds tracked by Wall St. Rank hold PRCT as of Q2 2026.

KRS Capital Management held 45,610 shares of Procept Biorobotics worth $1.03M as of Q2 2026.
KRS Capital Management sold 125 Procept Biorobotics shares in Q2 2026, an estimated $3.13K.
Procept Biorobotics made up 0.48% of KRS Capital Management's portfolio in Q2 2026, its #38 holding.
KRS Capital Management first reported a position in Procept Biorobotics in Q2 2024 and has held it in 9 quarters since.
KRS Capital Management's Procept Biorobotics position peaked at $3.74M in Q4 2024.
55 funds tracked by Wall St. Rank held Procept Biorobotics as of Q2 2026.

Based on KRS Capital Management's 13F filing for Q2 2026, filed 20 Jul 2026.